In order to further explore patient and tumor characteristics of DGST-PIT1/SF1, DGST-PIT1, and SGST-PIT1 across studies in a large meta-analysis, we integrated clinicopathological data of our in-house series and public deposits of five previously published studies [6, 11, 17, 20, 23]. The gene discussed is SF1; the disease is neoplasm.